David Nathanson

Publications
CV
Public outreach and news

Articles

Article: DIABETIC MEDICINE. 2024;41(5):e15259
Standardising personalised diabetes care across European health settings: A person-centred outcome set agreed in a multinational Delphi study
Porth A-K; Huberts AS; Rogge A; Benard AHM; Forbes A; Strootker A; Del Pozo CH; Kownatka D; Hopkins D; Nathanson D; Aanstoot H-J; Soderberg J; Eeg-Olofsson K; Hamilton K; Delbecque L; Ninov L; Due-Christensen M; Leutner M; Simo R; Vikstrom-Greve S; Roessner S; Flores V; Seidler Y; Hasler Y; Stamm T; Kautzky-Willer A
Article: BMJ OPEN. 2023;13(4):e069037
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study
Ritsinger V; Bodegard J; Kristofi R; Thuresson M; Nathanson D; Nystrom T; Eriksson J; Norhammar A
Article: ENDOCRINE. 2023;79(3):455-458
Hypoglycemia after exposure of diclofenac medication
Falhammar H; Torring O; Larsson M; Nathanson D
Article: CARDIOVASCULAR DIABETOLOGY. 2022;21(1):282
Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data
Kristofi R; Bodegard J; Ritsinger V; Thuresson M; Nathanson D; Nystrom T; Norhammar A; Eriksson JW
Article: DIABETES CARE. 2022;45(12):3040-3049
Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study
Brinck J; Hagstrom E; Natman J; Franzen S; Eeg-Olofsson K; Nathanson D; Eliasson B
Article: LAKARTIDNINGEN. 2022;119:21210
[Digiphysical cascade screening model to diagnose familial hypercholesterolemia in relatives to an index case].
Littmann K; Kindborg G; Nathanson D; Brinck J
Article: DIABETOLOGIA. 2021;64(7):1595-1603
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls
Nathanson D; Svensson A-M; Miftaraj M; Franzen S; Bolinder J; Eeg-Olofsson K
Article: DIABETES CARE. 2021;44(5):1211-1218
Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study
Kristofi R; Bodegard J; Norhammar A; Thuresson M; Nathanson D; Nystrom T; Birkeland KI; Eriksson JW
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2020;105(10):dgaa194-e3705
Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population-Based Case-Control Study
Falhammar H; Skov J; Calissendorff J; Nathanson D; Lindh JD; Mannheimer B
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29(1):77-83
Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden: A population-based register study
Bergh CF; Toivanen S; Johnell K; Calissendorff J; Skov J; Falhammar H; Nathanson D; Lindh JD; Mannheimer B
Article: DIABETES, OBESITY AND METABOLISM. 2019;21(12):2651-2659
Dapagliflozin vs non-SGLT-2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE-TIMI 58 trial: A nationwide observational study
Norhammar A; Bodegard J; Nystrom T; Thuresson M; Rikner K; Nathanson D; Eriksson JW
Article: ACTA NEUROLOGICA SCANDINAVICA. 2019;140(6):443-448
Prehospital exenatide in hyperglycemic stroke-A randomized trial
Larsson M; Castren M; Lindstrom V; von Euler M; Patrone C; Wahlgren N; Nathanson D
Article: ENDOCRINE. 2019;66(3):660-665
Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study
Mannheimer B; Skov J; Falhammar H; Calissendorff J; Lindh JD; Nathanson D
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2019;69:20-24
Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study
Falhammar H; Calissendorff J; Skov J; Nathanson D; Lindh JD; Mannheimer B
Article: CARDIOVASCULAR DIABETOLOGY. 2019;18(1):91
GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals
Larsson M; Patrone C; von Euler M; Holst JJ; Nathanson D
Article: DIABETES, OBESITY AND METABOLISM. 2019;21(5):1136-1145
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study
Norhammar A; Bodegard J; Nystrom T; Thuresson M; Nathanson D; Eriksson JW
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2019;60:71-77
Antipsychotics and severe hyponatremia: A Swedish population-based case-control study
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2019;59:65-69
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Article: PHARMACOECONOMICS - OPEN. 2018;2(4):393-402
Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014
Nathanson D; Sabale U; Eriksson JW; Nystrom T; Norhammar A; Olsson U; Bodegard J
Article: ENDOCRINOLOGY, DIABETES & METABOLISM. 2018;1(4):e00036
Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study
Persson F; Bodegard J; Lahtela JT; Nystrom T; Jorgensen ME; Jensen ML; Gulseth HL; Thuresson M; Hoti F; Nathanson D; Norhammar A; Birkeland KI; Eriksson JG; Eriksson JW
Article: SEIZURE. 2018;59:28-33
Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population-based case-control study
Falhammar H; Lindh JD; Calissendorff J; Farmand S; Skov J; Nathanson D; Mannheimer B
Article: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2018;6(1):14
Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin
Lietzau G; Davidsson W; Ostenson C-G; Chiazza F; Nathanson D; Pintana H; Skogsberg J; Klein T; Nystrom T; Darsalia V; Patrone C
Article: LAKARTIDNINGEN. 2018;115:EXDT
Många läkemedel – både nya och gamla – sänker blodglukos - För att ge patienten optimal läkemedelsbehandling krävs kännedom om patofysiologi och verkningsmekanismer.
Nyström T; Nathanson D
Article: DIABETES, OBESITY AND METABOLISM. 2018;20(2):344-351
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study
Persson F; Nystrom T; Jorgensen ME; Carstensen B; Gulseth HL; Thuresson M; Fenici P; Nathanson D; Eriksson JW; Norhammar A; Bodegard J; Birkeland KI
Article: AMERICAN JOURNAL OF MEDICINE. 2018;131(1):56-63
Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia
Farmand S; Lindh JD; Calissendorff J; Skov J; Falhammar H; Nathanson D; Mannheimer B
Article: BMJ OPEN. 2017;7(10):e016311
Safety of thrombolysis in stroke mimics: an observational cohort study from an urban teaching hospital in Sweden
Kostulas N; Larsson M; Kall T-B; von Euler M; Nathanson D
Article: THE LANCET DIABETES AND ENDOCRINOLOGY. 2017;5(9):709-717
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
Birkeland KI; Jorgensen ME; Carstensen B; Persson F; Gulseth HL; Thuresson M; Fenici P; Nathanson D; Nystrom T; Eriksson JW; Bodegard J; Norhammar A
Article: DIABETES, OBESITY AND METABOLISM. 2017;19(6):831-841
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetese
Nystrom T; Bodegard J; Nathanson D; Thuresson M; Norhammar A; Eriksson JW
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2017;123:199-208
Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia
Nystrom T; Bodegard J; Nathanson D; Thuresson M; Norhammard A; Eriksson JW
Article: BIOSCIENCE REPORTS. 2016;36(6):e00421
Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4
Larsson M; Lietzau G; Nathanson D; Ostenson C-G; Mallard C; Johansson ME; Nystrom T; Patrone C; Darsalia V
Article: DIABETOLOGIA. 2016;59(8):1692-1701
Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013
Norhammar A; Bodegard J; Nystrom T; Thuresson M; Eriksson JW; Nathanson D
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2016;117:39-47
Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality
Eriksson JW; Bodegard J; Nathanson D; Thuresson M; Nystrom T; Norhammare A
Article: DIABETES, OBESITY AND METABOLISM. 2016;18(5):537-541
Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor
Darsalia V; Larsson M; Lietzau G; Nathanson D; Nystrom T; Klein T; Patrone C
Article: DIABETOLOGY AND METABOLIC SYNDROME. 2016;8:5
Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure
Nathanson D; Frick M; Ullman B; Nystrom T
Article: PLOS ONE. 2016;11(6):e0156867
Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu
Mansouri S; Lietzau G; Lundberg M; Nathanson D; Nystrom T; Patrone C
Article: LAKARTIDNINGEN. 2015;112:DF37
[Vitamin D intoxication caused by drugs bought online. Sky high daily dosage for six months resulted in severe hypercalcemia].
Mannheimer B; Törring O; Nathanson D
Article: REGULATORY PEPTIDES. 2014;190:25-31
Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice
Darsalia V; Olverling A; Larsson M; Mansouri S; Nathanson D; Nystrom T; Klein T; Sjoholm A; Patrone C
Article: STROKE RESEARCH AND TREATMENT. 2014;2014:747458-7
Sex, diastolic blood pressure, and outcome after thrombolysis for ischemic stroke.
Nathanson D; Patrone C; Nyström T; von Euler M
Article: PLOS ONE. 2014;9(8):e103114
Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization
Darsalia V; Hua S; Larsson M; Mallard C; Nathanson D; Nystroem T; Sjoeholm A; Johansson ME; Patrone C
Article: DIABETOLOGIA. 2012;55(4):926-935
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety
Nathanson D; Ullman B; Lofstrom U; Hedman A; Frick M; Sjoholm A; Nystrom T
Article: DIABETIC MEDICINE. 2011;28(3):301-305
Plasma levels of glucagon like peptide-1 associate with diastolic function in elderly men
Nathanson D; Zethelius B; Berne C; Lind L; Andren B; Ingelsson E; Holst JJ; Nystroem T
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2010;325(1-2):26-35
Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor
Erdogdu O; Nathanson D; Sjoholm A; Nystrom T; Zhang Q
Article: DIABETOLOGIA. 2010;53(2):277-280
Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease
Nathanson D; Zethelius B; Berne C; Holst JJ; Sjoholm A; Nystrom T
Article: REGULATORY PEPTIDES. 2009;157(1-3):8-13
Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo
Nathanson D; Erdogdu O; Pernow J; Zhang Q; Nystrom T
Article: LAKARTIDNINGEN. 2005;102(16):1231-1233
[Amiodarone treatment against atrial fibrillation caused thyrotoxicosis].
Nathanson D; Calissendorff J; Lindhe C; Röjdmark S
Show more

All other publications

Review: PATIENT EDUCATION AND COUNSELING. 2023;116:107933
Which diabetes specific patient reported outcomes should be measured in routine care? A systematic review to inform a core outcome set for adults with Type 1 and 2 diabetes mellitus: The European Health Outcomes Observatory (H2O) programme
Hamilton K; Forde R; Due-Christensen M; Eeg-Olofson K; Nathanson D; Rossner S; Vikstrom-Greve S; Porth A-K; Seidler Y; Kautzky-Willer A; Delbecque L; Saltik AZO; Hasler Y; Floresi V; Stamm T; Hopkins D; Forbes A
Corrigendum: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2021;92:142-143
Antipsychotics and severe hyponatremia: A Swedish population-based case-control study (vol 60, pg 71, 2019)
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Corrigendum: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2021;92:140-141
Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study (vol 69, pg 20, 2019)
Falhammar H; Calissendorff J; Skov J; Nathanson D; Lindh JD; Mannheimer B
Corrigendum: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2021;91:107-108
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study (vol 59, pg 65, 2019)
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Corrigendum: AMERICAN JOURNAL OF MEDICINE. 2021;134(4):554
Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia (vol 131, pg 56, 2017)
Farmand S; Lindh JD; Calissendorff J; Skov J; Falhammar H; Nathanson D; Mannheimer B
Corrigendum: ENDOCRINE. 2021;71(2):531
Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study (vol 66, pg 660, 2019)
Mannheimer B; Skov J; Falhammar H; Calissendorff J; Lindh JD; Nathanson D
Corrigendum: SEIZURE. 2021;84:99-100
Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population-based case-control study (vol 59, pg 28, 2018)
Falhammar H; Lindh JD; Calissendorff J; Farmand S; Skov J; Nathanson D; Mannheimer B
Letter: DIABETES CARE. 2018;41(6):e104-e105
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10
Nystrom T; Bodegard J; Nathanson D; Thuresson M; Norhammar A; Eriksson JW
Review: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2015;35(5):718-723
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke
Darsalia V; Larsson M; Nathanson D; Klein T; Nystrom T; Patrone C
Review: REVIEWS IN ENDOCRINE AND METABOLIC DISORDERS. 2014;15(3):233-242
GLP-1R activation for the treatment of stroke: Updating and future perspectives
Darsalia V; Nathanson D; Nystrom T; Klein T; Sjoholm A; Patrone C
Thesis / dissertation: 2010
Studies on incretins and cardiovascular function
Nathanson, David
Review: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2009;297(1-2):112-126
Hypoglycemic pharmacological treatment of type 2 diabetes: Targeting the endothelium
Nathanson D; Nystrom T

Employments

Affiliated to Research, Department of Medicine, Huddinge, Karolinska Institutet, 2023-2026

Degrees and Education

Docent, Karolinska Institutet, 2020
Degree Of Doctor Of Philosophy, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 2010
University Medical Degree, Karolinska Institutet, 1995

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI